Related Experiment Video

Updated: Jun 5, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

870

Ferroptosis in Cardiovascular Diseases and Ferroptosis-Related Intervention Approaches

Xianpeng Zhou1, Hao Wang1, Biao Yan1

  • 1Hubei University of Science and Technology, Xianning, 437100, Hubei, People's Republic of China.

Cardiovascular Drugs and Therapy
|December 6, 2024
PubMed

Insights

This review explores ferroptosis, a cell death process, and its therapeutic potential for cardiovascular diseases (CVDs). Targeting ferroptosis offers promising strategies for preventing and treating CVDs, though clinical translation requires further research.

Area of Science:

  • Biomedical Science
  • Cardiovascular Research
  • Cell Death Mechanisms

Background:

  • Cardiovascular diseases (CVDs) represent a significant global health burden.
  • Ferroptosis, a regulated form of cell death, is increasingly implicated in CVD pathogenesis.
  • Understanding ferroptosis is crucial for developing novel therapeutic interventions.

Purpose of the Study:

  • To review recent advancements in ferroptosis research concerning cardiovascular diseases.
  • To explore ferroptosis-related intervention strategies for CVD treatment.
  • To provide a foundation for future research on ferroptosis in CVDs.

Main Methods:

  • Comprehensive literature review.
  • Analysis of existing research on ferroptosis and CVDs.
  • Synthesis of findings on ferroptosis-targeted therapies.

Main Results:

  • Ferroptosis plays a key role in the development of cardiovascular diseases.
  • Ferroptosis-targeted compounds and genes show potential for CVD treatment.
  • The review consolidates current knowledge on ferroptosis in CVDs.

Conclusions:

  • Ferroptosis-targeted therapies hold promise for cardiovascular disease treatment.
  • Challenges exist in translating ferroptosis research to clinical practice.
  • Further investigation is needed for safer and more effective ferroptosis-targeted approaches for CVDs.
Abstract

Keywords:
Amino acid metabolismCardiovascular diseasesFerroptosisIron metabolismLipid metabolism

More Related Videos

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence10:52

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence

Published on: December 23, 2022

3.1K
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

3.8K

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.3K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
557
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
2
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
2
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K